Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis

被引：8
|
作者：
Bourdette, Dennis [1 ,2 ]
Hartung, Daniel [3 ]
机构：
[1] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA
[2] Vet Affairs Portland Hlth Care Syst, Multiple Sclerosis Ctr Excellence West, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Oregon State Univ, Coll Pharm, Portland, OR 97201 USA
来源：
JAMA NEUROLOGY | 2015年 / 72卷 / 12期
关键词：
TRIAL; MULTICENTER; COPAXONE(R); COP-1; DRUGS;
D O I：
10.1001/jamaneurol.2015.2605
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1411 / 1413
页数：4
相关论文
共 50 条
  • [21] Long Term Treatment of Multiple Sclerosis with Glatiramer Acetate: Natural History of the Subtypes of Anti-Glatiramer Acetate Antibodies and Their Correlation with Clinical Efficacy
    Brenner, Talma
    Teitelbaum, Dvora
    Sicsic, Camille
    Karussis, Dimitrios
    NEUROLOGY, 2010, 74 (09) : A423 - A423
  • [22] Glatiramer acetate: Mechanisms of action in multiple sclerosis
    Ziemssen, Tjalf
    Schrempf, Wiebke
    NEUROBIOLOGY OF MULTIPLE SCLEROSIS, 2007, 79 : 537 - 570
  • [23] Is glatiramer acetate better for pregnancy in multiple sclerosis?
    Kasatkin, D. S.
    Vinogradova, T. V.
    Shitova, A. S.
    Spirin, N. N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E307 - E308
  • [24] Glatiramer acetate (Copaxone®) therapy for multiple sclerosis
    Dhib-Jalbut, S
    PHARMACOLOGY & THERAPEUTICS, 2003, 98 (02) : 245 - 255
  • [25] Evidence for use of glatiramer acetate in multiple sclerosis
    Caramanos, Z
    Arnold, DL
    LANCET NEUROLOGY, 2005, 4 (02): : 74 - 75
  • [26] Treatment Challenges in Multiple Sclerosis - A Continued Role for Glatiramer Acetate?
    Mirabella, Massimiliano
    Annovazzi, Pietro
    Brownlee, Wallace
    Cohen, Jeffrey A.
    Kleinschnitz, Christoph
    Wolf, Christian
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [27] Economic impact of glatiramer acetate in multiple sclerosis
    Ollendorf, DA
    Jilinskaia, E
    Oleen-Burkey, M
    VALUE IN HEALTH, 2002, 5 (06) : 510 - 511
  • [28] Glatiramer acetate: Mechanisms of action in multiple sclerosis
    Schrempf, Wiebke
    Ziemssen, Tjalf
    AUTOIMMUNITY REVIEWS, 2007, 6 (07) : 469 - 475
  • [29] Lipoatrophy in patients with multiple sclerosis on glatiramer acetate
    Edgar, CM
    Brunet, DG
    Fenton, P
    McBride, EV
    Green, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2004, 31 (01) : 58 - 63
  • [30] Glatiramer acetate therapy for multiple sclerosis: a review
    Perumal, Jai
    Filippi, Massimo
    Ford, Corey
    Johnson, Kenneth
    Lisak, Robert
    Metz, Luanne
    Tselis, Alexandros
    Tullman, Mark
    Khan, Omar
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (06) : 1019 - 1029
12345